ArticlePsoriasis (Auckland, N.Z.)2025

Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis.

Min Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.